Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levagen+ topical cream in eczema
NCT05003453Phase 3Completed
- Sponsor
- RDC Clinical
- Start
- Nov 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing Levagen+ Cream with Placebo Cream (2 arms). Primary endpoint: Self-Assessed Eczema Area and Severity Index at 4 weeks. Started Nov 2021; status: completed.
02
Drugs
palmitoylethanolamide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05003453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05003453.